Regional Forecast | Company & Drug | Global | 2023

Regional Forecast is an add on offering from Clarivate’s Company & Drugs (C&D) that renders extended coverage of existing C&D proprietary data. With increasing demand to analyze the data in much granularity, market forecasters can now have an in-depth analysis of the data which is now available for different segments (such as therapy area, drug group and drug class) across multiple regions (U.S., Europe, Japan and Others).

Data is readily accessible in the form of downloadable reports / interactive dashboard which enables the user to navigate and analyze the data quickly and easily. Data is covered for fourteen therapeutic areas mentioned below:

  • Anti-Infectives
  • Cardiovasculars
  • Central Nervous System
  • Dermatology
  • Gastrointestinal
  • Genitourinary
  • Hematology
  • Metabolism
  • Musculoskeletal Pain
  • Oncology
  • Ophthalmology
  • Respiratory
  • Transplant
  • Vaccines

User Guidelines:

1.Dashboard has three tabs – ‘Regional Data’, ‘Base Year Analysis’ and ‘Forecast Analysis’

    a.‘Regional Data’ tab details the regional level sales for individual drug classes consolidated at  

        drug group and therapy area levels

    b.‘Base Year Analysis’ tab enables the user to quickly analyze and compare sales at drug

        class and drug group levels

    c.‘Forecast Analysis’ tab enables the user to assess the forecast     

Login to access report